Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Dental Anesthesia Market

ID: MRFR/MED/11824-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
US Dental Anesthesia Market Research Report: Size, Share, Trend Analysis By Product Type (lidocaine, mepivacaine, prilocaine, bupivacaine 0.5% with epinephrine1:200,000, articaine, others), By Mode of Administration (maxillary, mandibular, others), By Technique (local infiltration, field block, nerve block), By Duration of Action (short, medium, long), By End Users (hospital clinics, clinics, other), By Distribution Channel (pharmacies and drug stores, e-commerce, other) and By Intended Audience (hospitals, dental clinics, research institutes, dental software manufacturers, healthcare it companies) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Security, Access Control and Robotics, BY Product Type (USD Million)
      1. 4.1.1 Lidocaine
      2. 4.1.2 Mepivacaine
      3. 4.1.3 Prilocaine
      4. 4.1.4 Bupivacaine 0.5% with epinephrine 1:200,000
      5. 4.1.5 Articaine
      6. 4.1.6 Others
    2. 4.2 Security, Access Control and Robotics, BY Mode of Administration (USD Million)
      1. 4.2.1 Maxillary
      2. 4.2.2 Mandibular
      3. 4.2.3 Others
    3. 4.3 Security, Access Control and Robotics, BY Technique (USD Million)
      1. 4.3.1 Local Infiltration
      2. 4.3.2 Field Block
      3. 4.3.3 Nerve Block
    4. 4.4 Security, Access Control and Robotics, BY Duration of Action (USD Million)
      1. 4.4.1 Short
      2. 4.4.2 Medium
      3. 4.4.3 Long
    5. 4.5 Security, Access Control and Robotics, BY End User (USD Million)
      1. 4.5.1 Hospital Clinics
      2. 4.5.2 Clinics
      3. 4.5.3 Other
    6. 4.6 Security, Access Control and Robotics, BY Distribution Channel (USD Million)
      1. 4.6.1 Pharmacies And Drug Stores
      2. 4.6.2 E-Commerce
      3. 4.6.3 Other
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Dentsply Sirona (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Henry Schein (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Patterson Companies (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Septodont (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Heraeus Kulzer (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 3M (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 B. Braun (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Kavo Kerr (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 DentalEZ (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 US MARKET ANALYSIS BY MODE OF ADMINISTRATION
    4. 6.4 US MARKET ANALYSIS BY TECHNIQUE
    5. 6.5 US MARKET ANALYSIS BY DURATION OF ACTION
    6. 6.6 US MARKET ANALYSIS BY END USER
    7. 6.7 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    8. 6.8 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
    9. 6.9 RESEARCH PROCESS OF MRFR
    10. 6.10 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
    11. 6.11 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
    12. 6.12 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
    13. 6.13 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
    14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY MODE OF ADMINISTRATION, 2024 (% SHARE)
    17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY MODE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
    18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNIQUE, 2024 (% SHARE)
    19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNIQUE, 2024 TO 2035 (USD Million)
    20. 6.20 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DURATION OF ACTION, 2024 (% SHARE)
    21. 6.21 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DURATION OF ACTION, 2024 TO 2035 (USD Million)
    22. 6.22 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END USER, 2024 (% SHARE)
    23. 6.23 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END USER, 2024 TO 2035 (USD Million)
    24. 6.24 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    25. 6.25 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Million)
      3. 7.2.3 BY TECHNIQUE, 2025-2035 (USD Million)
      4. 7.2.4 BY DURATION OF ACTION, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
      6. 7.2.6 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Product Type (USD Million, 2025-2035)

  • Lidocaine
  • Mepivacaine
  • Prilocaine
  • Bupivacaine 0.5% with epinephrine 1:200,000
  • Articaine
  • Others

Security, Access Control and Robotics By Mode of Administration (USD Million, 2025-2035)

  • Maxillary
  • Mandibular
  • Others

Security, Access Control and Robotics By Technique (USD Million, 2025-2035)

  • Local Infiltration
  • Field Block
  • Nerve Block

Security, Access Control and Robotics By Duration of Action (USD Million, 2025-2035)

  • Short
  • Medium
  • Long

Security, Access Control and Robotics By End User (USD Million, 2025-2035)

  • Hospital Clinics
  • Clinics
  • Other

Security, Access Control and Robotics By Distribution Channel (USD Million, 2025-2035)

  • Pharmacies And Drug Stores
  • E-Commerce
  • Other